[Novel coronavirus disease (COVID-19) and obstructive sleep apnea: age aspects of comorbidity].
Olga N BerdinaIrina M MadaevaL V RychkovaPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2021)
In connection with the spread of the novel coronavirus infection (COVID-19) pandemic and the increase in the development of severe acute respiratory syndrome, works are published around the world that determined the risk factors for complications and poor outcomes in this disease. Among the main comorbidities in COVID-19, scientists distinguish hypertension, diabetes, obesity, etc. Recently, more and more physicians and researchers are concerned about the high frequency of severe and critical complications of COVID-19 in patients with obstructive sleep apnea (OSA). In this review, we present some data on COVID-19 and OSA in the age aspect, show the general pathophysiological pathways leading to increased systemic inflammation and adverse consequences in the comorbid course of these diseases. Special attention is paid to such studies in the pediatric population, but only a few works of foreign scientists were found that did not reveal the essence of the problem under discussion, which requires further research in this area.
Keyphrases
- coronavirus disease
- obstructive sleep apnea
- high frequency
- sars cov
- positive airway pressure
- respiratory syndrome coronavirus
- type diabetes
- transcranial magnetic stimulation
- blood pressure
- primary care
- metabolic syndrome
- sleep apnea
- insulin resistance
- weight loss
- cardiovascular disease
- gene expression
- randomized controlled trial
- glycemic control
- adipose tissue
- case report
- deep learning
- early onset